Abstract
The global pandemic due to infection with the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV -2) causes the disease COVID-19 which is a mild, self-limiting disease in the majority of infected individuals.1 However, in many individuals, particularly the elderly, or those with comorbidities such as diabetes, pulmonary disease or cardiovascular conditions, infection with SARS-CoV-2 has resulted in more severe symptoms, and has proved fatal.2
Given that COVID-19 is a novel disease and that there is no vaccine or specific pharmacologic treatment for it, it is likely that its impact on an individual's general health will be protracted and is yet to unfold. Oral health is inextricably linked to general health and its neglect may have negative consequences on human and economic capital. The aim of this commentary is, therefore, to highlight the potential impact of SARS-CoV-2 on oral health in South Africa (SA).
Publisher
Academy of Science of South Africa
Reference53 articles.
1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Auto-immun. 2020; 109: 102433.
2. Porcheddu R, Serra C, Kelvin D, Kelvin N, Rubino S. Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China. J Infect Dev Ctries. 2020; 14(2): 125-8.
3. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020; 581(7807): 221-4.
4. Hamming I, Timens W, Bulthuis ML, Lely AT, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004; 203(2): 631-7.
5. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020.